Pathway

Lower GI

Rating:

Some interesting sessions on how to manage low gastro-intestinal oncology.

Share on:

Pathway sessions:

The role of MRgRT in pelvic malignancies

Vincenzo Valentini

23.07.2020

Colon cancer adjuvant therapy in 2020 (20MCO)

Demetris Papamichael

27.03.2020

The role of molecular biomarkers and treatment landscape for advanced colorectal cancer

Nora Forones

23.04.2020

Future trends of molecular testing and BRAF inhibitors for advanced colorectal cancer treatment

Antonia Digklia

10.12.2020

The role of immune-checkpoints inhibitors for advanced colorectal cancer treatment

Ramon Andrade Bezerra de Mello

25.03.2020

Highlights of ESMO 2020 - Focus on colorectal and anal cancer

Andrés Cervantes Ruiperez

08.10.2020

Palliation in colorectal cancer - Stent or surgery? (20EGC)

Pieter Tanis

When to perform EMR and when ESD in colorectal premalignant changes in early cancer? (20EGC)

Massimo Conio

How to perform screening for colorectal cancer: FOBT/FIT/stool DNA/capsule, scope or CT (20EGC)

Jaroslaw Regula

Top